David Kozono, MD, PhD, Associate Professor of Radiation Oncology at Harvard Medical School and Program Director of Thoracic Radiation Oncology at Mass General Brigham Cancer Center (IMAGE)
Caption
A new clinical research study is now open to explore whether a more targeted form of radiation therapy lowers the chance of lung cancer returning after surgery. The study (Alliance A082402) is for people with non‑small cell lung cancer (NSCLC) who underwent chemotherapy and immunotherapy before surgery, but who still have cancer cells found in lymph nodes at the time of their operation. This is a situation many patients with lung cancer face.
“We already know that chemotherapy and immunotherapy can help when given before or after lung cancer surgery. This study is asking an important question: Does adding targeted radiation lower the risk of NSCLC returning without causing long‑term side effects?” said study co-chair David Kozono, MD, PhD, Associate Professor of Radiation Oncology at Harvard Medical School and Program Director of Thoracic Radiation Oncology at Mass General Brigham Cancer Center.
Credit
Harvard Medical School
Usage Restrictions
none
License
Original content